Embold Health is a healthcare technology company that helps employers and health plans improve patient outcomes and lower healthcare costs through physician performance data. It was founded in 2017 and is based in Nashville, Tennessee.
UpMarket does not offer Embold Health shares. This page covers Embold Health's history before the acquisition.
Embold Health was acquired by Quantum Health in June 2025 and no longer has shares of its own. UpMarket does not offer Embold Health shares. This page covers Embold Health's valuation and funding history before the acquisition.
Embold Health was acquired by Quantum Health in June 2025.
See how Embold Health's private-market valuation changed across funding rounds before the acquisition.
See reported funding rounds and revenue figures on this page, with their sources.
Accredited investors can review UpMarket's current pre-IPO offerings in companies that have not yet gone public.
Pre-IPO investments are illiquid, speculative, and involve risk of total loss of capital.
| Date | Round | PPS (split-adj.) | Valuation |
|---|---|---|---|
| Aug 2021 | Series C | ||
| Jul 2020 | Series B | ||
| Oct 2018 | Series A |
Embold Health said its 2025 results delivered "major growth" alongside measurable employer savings and scaled impact. The update highlights company momentum after its Series B financing and broader adoption of its physician quality analytics tools.
Embold Health raised $23 million in Series B funding, led by Echo Health Ventures, with Morgan Health contributing $5 million. The company said the capital will expand access to physician quality data and support national growth.
Embold says its provider engagement products surface objective, clinically validated insights to help providers understand performance and identify growth opportunities. The company's member guidance materials also use complex clinical data to steer employees toward higher-quality care choices.
Looking for companies that are still private? Browse UpMarket's pre-IPO company directory. Accredited investors only.
Browse the directory →UpMarket curates and conducts independent diligence on every investment opportunity before it reaches the platform.
We review every offering's strategy, risk management, liquidity, fees, valuation methodology, tax matters, and all third-party providers: legal counsel, auditor, administrator, and custodian.
We offer investments exclusively from disciplined managers that pursue unique strategies across an array of asset classes.
Our goal is to empower you to build a portfolio that best meets your individual investment objectives.
No. Embold Health was acquired by Quantum Health in June 2025 and no longer has shares of its own. UpMarket does not offer Embold Health shares.
Embold Health has no stock price of its own since its acquisition by Quantum Health. The prices shown on this page are historical private-market prices from before the acquisition.
No. Embold Health was acquired by Quantum Health and UpMarket does not offer Embold Health shares. Accredited investors interested in companies that have not yet gone public can review UpMarket's current pre-IPO offerings.
Embold Health is no longer an independent company, so its shares are not available to buy. This page is kept for its historical funding and valuation data. UpMarket does not offer Embold Health shares.
In a pre-IPO transaction, accredited investors purchase shares from existing shareholders (such as employees, early investors, or other holders) through secondary market platforms. The company itself does not issue new shares in these transactions. UpMarket facilitates these trades as a FINRA-registered broker-dealer, handling compliance, documentation, and settlement on behalf of both parties.
Embold Health was acquired by Quantum Health in June 2025. What former shareholders received, cash or shares of the buyer, was set by the terms of the acquisition.
UpMarket does not offer Embold Health shares. The minimum for most pre-IPO offerings on UpMarket is $50,000.
Embold Health's last valuation was set by its acquisition by Quantum Health. The figures on this page show its valuation history before the acquisition.
Embold Health helps employers and health plans improve patient outcomes and lower healthcare costs through physician performance data, and says 2025 was a breakout year with scaled impact. Embold Health is now part of Quantum Health, and UpMarket does not offer its shares.